NCT01326871 2024-06-25
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Altor BioScience
Phase 1/2 Completed
Altor BioScience
National Cancer Institute (NCI)
Mayo Clinic
University Health Network, Toronto
H. Lee Moffitt Cancer Center and Research Institute